Co-Administration of Inhibitors of HDAC6 and SGLT2 in Murine HFpEF Models Results in Additive Improvements in Cardiac Structural and Functional Measures
Farshad Farshidfar(Institute for Stem Cell Biology and Regenerative Medicine), Timothy Hoey, Aliya Zeng, Cindy Li, Sara Ranjbarvaziri(Unknown), Xiaomei Song, Anastasiia Budan, Charles Mackay, Gretchen Argast(Rapt Therapeutics (United States)), Iris Wu(University of Michigan), James R. Priest(Cardiovascular Institute of the South), Jin Yang(Rapt Therapeutics (United States)), Reva Shenwai, Matthew Kozubov, Emma Xu(Columbia University), Melissa Van Pell, Amara Greer-Short(Unknown)
Cited by 2
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics
|British Journal of Cancer|2016|136
Epidermal Growth Factor Receptor Transactivation Mediates Tumor Necrosis Factor-induced Hepatocyte Replication
|Journal of Biological Chemistry|2004|104
Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state
|Proceedings of the National Academy of Sciences|2021|81